Title of Collaborative Activity: |
Coccidioidomycosis (Valley Fever): Considerations for Development of Antifungal Drugs |
Description of Collaborative Activity: |
A virtual public workshop sponsored by FDA for coccidioidomycosis (Valley Fever) pertaining to landscape and considerations for developing antifungal drugs. Discussions will focus on the current state and clinical trial design considerations related to coccidioidomycosis. |
Type of Collaborative Activity: |
Meeting/ Workshop
|
Year the Collaborative Activity Originated: |
2020 |
NIH Participating Institutes/Centers/Office of the Director: |
NIAID |
HHS Agency Collaborators on this Activity: |
FDA |
